Literature DB >> 15980368

Antifolate activity of epigallocatechin gallate against Stenotrophomonas maltophilia.

María Dolores Navarro-Martínez1, Enma Navarro-Perán, Juan Cabezas-Herrera, Joaquín Ruiz-Gómez, Francisco García-Cánovas, José Neptuno Rodríguez-López.   

Abstract

The catechin epigallocatechin gallate, one of the main constituents of green tea, showed strong antibiotic activity against 18 isolates of Stenotrophomonas maltophilia (MIC range, 4 to 256 microg/ml). In elucidating its mechanism of action, we have shown that epigallocatechin gallate is an efficient inhibitor of S. maltophilia dihydrofolate reductase, a strategic enzyme that is considered an attractive target for the development of antibacterial agents. The inhibition of S. maltophilia dihydrofolate reductase by this tea compound was studied and compared with the mechanism of a nonclassical antifolate compound, trimethoprim. Investigation of dihydrofolate reductase was undertaken with both a trimethoprim-susceptible S. maltophilia isolate and an isolate with a high level of resistance. The enzymes were purified using ammonium sulfate precipitation, gel filtration, and methotrexate affinity chromatography. The two isolates showed similar levels of dihydrofolate reductase expression and similar substrate kinetics. However, the dihydrofolate reductase from the trimethoprim-resistant isolate demonstrated decreased susceptibility to inhibition by trimethoprim and epigallocatechin gallate. As with other antifolates, the action of epigallocatechin gallate was synergistic with that of sulfamethoxazole, a drug that blocks folic acid metabolism in bacteria, and the inhibition of bacterial growth was attenuated by including leucovorin in the growth medium. We conclude that the mechanism of action of epigallocatechin gallate on S. maltophilia is related to its antifolate activity.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15980368      PMCID: PMC1168674          DOI: 10.1128/AAC.49.7.2914-2920.2005

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  37 in total

1.  Class 1 integrons increase trimethoprim-sulfamethoxazole MICs against epidemiologically unrelated Stenotrophomonas maltophilia isolates.

Authors:  Raquel Barbolla; Mariana Catalano; Betina E Orman; Angela Famiglietti; Carlos Vay; Jorgelina Smayevsky; Daniela Centrón; Silvia A Piñeiro
Journal:  Antimicrob Agents Chemother       Date:  2004-02       Impact factor: 5.191

2.  Slow-binding inhibition: A theoretical and practical course for students.

Authors:  Marko Goliĉnik; Jure Stojan
Journal:  Biochem Mol Biol Educ       Date:  2004-07       Impact factor: 1.160

Review 3.  Trimethoprim and sulfonamide resistance.

Authors:  P Huovinen; L Sundström; G Swedberg; O Sköld
Journal:  Antimicrob Agents Chemother       Date:  1995-02       Impact factor: 5.191

4.  Porcine liver dihydrofolate reductase. Purification, properties, and amino acid sequence.

Authors:  S L Smith; P Patrick; D Stone; A W Phillips; J J Burchall
Journal:  J Biol Chem       Date:  1979-11-25       Impact factor: 5.157

5.  Epigallocatechin gallate synergistically enhances the activity of carbapenems against methicillin-resistant Staphylococcus aureus.

Authors:  Zhi-Qing Hu; Wei-Hua Zhao; Nozomi Asano; Yoshiyuki Yoda; Yukihiko Hara; Tadakatsu Shimamura
Journal:  Antimicrob Agents Chemother       Date:  2002-02       Impact factor: 5.191

6.  A single amino acid substitution in Staphylococcus aureus dihydrofolate reductase determines trimethoprim resistance.

Authors:  G E Dale; C Broger; A D'Arcy; P G Hartman; R DeHoogt; S Jolidon; I Kompis; A M Labhardt; H Langen; H Locher; M G Page; D Stüber; R L Then; B Wipf; C Oefner
Journal:  J Mol Biol       Date:  1997-02-14       Impact factor: 5.469

Review 7.  Stenotrophomonas maltophilia endocarditis.

Authors:  Nancy F Crum; Gregory C Utz; Mark R Wallace
Journal:  Scand J Infect Dis       Date:  2002

8.  Epigallocatechin gallate synergy with ampicillin/sulbactam against 28 clinical isolates of methicillin-resistant Staphylococcus aureus.

Authors:  Z Q Hu; W H Zhao; Y Hara; T Shimamura
Journal:  J Antimicrob Chemother       Date:  2001-09       Impact factor: 5.790

Review 9.  Clinical role of beta-lactam/beta-lactamase inhibitor combinations.

Authors:  Nelson Lee; Kwok-Yung Yuen; Cyrus R Kumana
Journal:  Drugs       Date:  2003       Impact factor: 9.546

10.  Bacteremia due to Stenotrophomonas (Xanthomonas) maltophilia: a prospective, multicenter study of 91 episodes.

Authors:  R R Muder; A P Harris; S Muller; M Edmond; J W Chow; K Papadakis; M W Wagener; G P Bodey; J M Steckelberg
Journal:  Clin Infect Dis       Date:  1996-03       Impact factor: 9.079

View more
  21 in total

Review 1.  Antibiotic resistance breakers: can repurposed drugs fill the antibiotic discovery void?

Authors:  David Brown
Journal:  Nat Rev Drug Discov       Date:  2015-10-23       Impact factor: 84.694

2.  Antimicrobial properties of green tea catechins.

Authors:  Peter W Taylor; Jeremy M T Hamilton-Miller; Paul D Stapleton
Journal:  Food Sci Technol Bull       Date:  2005

Review 3.  Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications.

Authors:  Brahma N Singh; Sharmila Shankar; Rakesh K Srivastava
Journal:  Biochem Pharmacol       Date:  2011-07-30       Impact factor: 5.858

4.  Green tea polyphenols function as prooxidants to inhibit Pseudomonas aeruginosa and induce the expression of oxidative stress-related genes.

Authors:  Xiaoxiang Liu; Jianrong Li; Yanbo Wang; Tingting Li; Jin Zhao; Chaohua Zhang
Journal:  Folia Microbiol (Praha)       Date:  2012-10-10       Impact factor: 2.099

5.  Cellular responses and proteomic analysis of Escherichia coli exposed to green tea polyphenols.

Authors:  Y S Cho; N L Schiller; H Y Kahng; K H Oh
Journal:  Curr Microbiol       Date:  2007-09-14       Impact factor: 2.188

Review 6.  Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea.

Authors:  J Steinmann; J Buer; T Pietschmann; E Steinmann
Journal:  Br J Pharmacol       Date:  2013-03       Impact factor: 8.739

7.  Antibacterial effects of green tea polyphenols on clinical isolates of methicillin-resistant Staphylococcus aureus.

Authors:  Yun-Seok Cho; Neal L Schiller; Kye-Heon Oh
Journal:  Curr Microbiol       Date:  2008-09-10       Impact factor: 2.188

8.  Green tea extract and its major constituent epigallocatechin-3-gallate inhibit growth and halitosis-related properties of Solobacterium moorei.

Authors:  Marie-Pierre Morin; Telma Blanca Lombardo Bedran; Jade Fournier-Larente; Bruno Haas; Jabrane Azelmat; Daniel Grenier
Journal:  BMC Complement Altern Med       Date:  2015-03-10       Impact factor: 3.659

Review 9.  Targeting the epigenetic machinery of cancer cells.

Authors:  M F Montenegro; L Sánchez-del-Campo; M P Fernández-Pérez; M Sáez-Ayala; J Cabezas-Herrera; J N Rodríguez-López
Journal:  Oncogene       Date:  2014-01-27       Impact factor: 9.867

10.  Effects of green tea compound epigallocatechin-3-gallate against Stenotrophomonas maltophilia infection and biofilm.

Authors:  Pedrina G Vidigal; Mathias Müsken; Katrin A Becker; Susanne Häussler; Jost Wingender; Eike Steinmann; Jan Kehrmann; Erich Gulbins; Jan Buer; Peter Michael Rath; Jörg Steinmann
Journal:  PLoS One       Date:  2014-04-01       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.